CARM

Carisma Therapeutics
CARM

Delisted

CARM was delisted on the 10th of October, 2025.

76 hedge funds and large institutions have $104M invested in Carisma Therapeutics in 2021 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 34 increasing their positions, 11 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

0.12% more ownership

Funds ownership: 1.07%1.18% (+0.12%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

19% less call options, than puts

Call options by funds: $2.58M | Put options by funds: $3.2M

Holders
76
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.58M
Puts
$3.2M
Net Calls
Net Calls Change

Top Buyers

1 +$7.81M
2 +$6.82M
3 +$5.88M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$3.38M
5
BlackRock
BlackRock
New York
+$2.65M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$396K
27
$392K
28
$382K
29
$360K
30
$325K
31
$305K
32
$273K
33
$263K
34
$237K
35
$211K
36
$206K
37
$161K
38
$149K
39
$147K
40
$129K
41
$117K
42
$114K
43
$110K
44
$97K
45
$93K
46
$78K
47
$65K
48
$63K
49
$61K
50
$56.7K